Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis.

Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis.
复制标题

DOI:
10.1007/s11920-023-01456-2
复制
发表时间:
2023-11
影响因子:
6.7
通讯作者:
Cadenhead KS
Cadenhead KS
中科院分区:
医学2区
文献类型:
--
作者:
Caballero N;Machiraju S;Diomino A;Kennedy L;Kadivar A;Cadenhead KS

文献摘要

参考文献

相似文献

本文综述了精神病性转换的预测和治疗的最新进展。在过去的25年中,对精神病前驱期的研究已经扩大,并有望早期识别可能转化为精神病的精神病临床高风险(HRD)个体。荟萃分析强调,使用现有的临床标准,2-3年内的转换率在20 - 30%之间,而对更具体的风险因素,生物标志物和精神病风险计算器的改进的研究已经爆炸,提高了我们预测精神病转换的能力。最近的研究强调了可能有助于早期识别的风险因素和生物标志物,并提供了对神经发育异常,神经发育亚型和干预措施的深入了解,这些干预措施可以针对与神经机制相关的特定风险特征。正在进行的评估早期精神病参与者长期(> 5-10年)结果的计划可以提供有关后期转换和诊断结果的预测因素的有价值信息,而大规模的国际生物标志物研究为精确干预提供了希望,这将改变全球早期精神病的进程。
This review highlights recent advances in the prediction and treatment of psychotic conversion. Over the past 25 years, research into the prodromal phase of psychotic illness has expanded with the promise of early identification of individuals at clinical high risk (CHR) for psychosis who are likely to convert to psychosis. Meta-analyses highlight conversion rates between 20 and 30% within 2–3 years using existing clinical criteria while research into more specific risk factors, biomarkers, and refinement of psychosis risk calculators has exploded, improving our ability to predict psychotic conversion with greater accuracy. Recent studies highlight risk factors and biomarkers likely to contribute to earlier identification and provide insight into neurodevelopmental abnormalities, CHR subtypes, and interventions that can target specific risk profiles linked to neural mechanisms. Ongoing initiatives that assess longer-term (> 5–10 years) outcome of CHR participants can provide valuable information about predictors of later conversion and diagnostic outcomes while large-scale international biomarker studies provide hope for precision intervention that will alter the course of early psychosis globally.
DOI: 10.1017/s0033291717000319
发表时间: 2017-08-01
影响因子: 6.9
作者:
Brucato, G.;Masucci, M. D.;Girgis, R. R.
通讯作者: Girgis, R. R.
DOI: 10.1016/j.schres.2019.01.015
发表时间: 2019-06-01
影响因子: 4.5
作者:
Brodey, B. B.;Girgis, R. R.;Cadenhead, K. S.
通讯作者: Cadenhead, K. S.
DOI: 10.1176/appi.ajp.162.1.71
发表时间: 2005-01-01
影响因子: 17.7
作者:
Brewer, WJ;Francey, SM;McGorry, PD
通讯作者: McGorry, PD
DOI: 10.1038/s41537-020-00117-0
发表时间: 2020-10-05
期刊: NPJ schizophrenia
影响因子: 5.4
作者:
Addington J;Farris M;Devoe D;Metzak P
通讯作者: Metzak P
DOI: 10.1111/eip.13175
发表时间: 2021-05-15
影响因子: 2
作者:
Bjornestad, Jone;Tjora, Tore;ten Velden Hegelstad, Wenche
通讯作者: ten Velden Hegelstad, Wenche